Thursday, October 20, 2011

Cumberland Pharmaceuticals Ranks as one of the fastest growing companies in North America.

NASHVILLE, Tenn., Oct. 20, 2011 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) today announced that it has been placed on Deloitte's 2011 Technology Fast 500 list, an annual ranking of the fastest growing technology, media, telecommunications, life sciences and clean technology companies in North America. Rankings are based on percentage of fiscal year revenue growth during the period from 2006 to 2010. Cumberland Pharmaceuticals grew 158% during this period.

"Cumberland Pharmaceuticals, like all 2011 Technology Fast 500 companies, has excelled in fostering innovation and channeling it into spectacular growth against the backdrop of one of the most challenging economies in history," said Eric Openshaw, vice chairman and U.S. technology, media and telecommunications leader, Deloitte LLP. "Deloitte recognizesCumberland for its remarkable accomplishment."

"We are pleased to honor Cumberland Pharmaceuticals as a 2011 Technology Fast 500 company," said Mark Jensen, managing partner, technology and venture capital services,

Deloitte & Touche LLP. "As one of the fastest growing tech companies in North America, Cumberland has demonstrated excellence in technological innovation, entrepreneurship and rapid growth."

Cumberland Pharmaceuticals' Chief Executive Officer, A.J. Kazimi, credits a commitment to providing differentiated products that help improve patient care as the driving force behind the Company's 158% revenue growth. "We are honored to be recognized among the innovative companies that comprise the 2011 Technology Fast 500 list," said Kazimi. "Our ability to deliver consistent revenue growth while providing real solutions for patients is a testament to the dedication and talent of our team. It is extremely rewarding to be honored by Deloitte for the second year in a row."